Zeolite Nanoparticles Inhibit Aβ–Fibrinogen Interaction and Formation of a Consequent Abnormal Structural Clot
Authors:
- Hossein DerakhshankhahHDHossein Derakhshankhah
- Ebrahim BarzegariEBEbrahim Barzegari
- Alireza LotfabadiALAlireza Lotfabadi
- Maryam FerdousiMFMaryam Ferdousi
- Ali Akbar SabouryASAli Akbar Saboury
- Eng Poh NgEng Poh Ng
- Mohammad RaoufiMRMohammad Raoufi
- Svetlana MintovaSvetlana Mintova
- Rassoul DinarvandRDRassoul Dinarvand
- Morteza MahmoudiMMMorteza Mahmoudi
- 1 November 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 8 (45) , 30768-30779
Abstract
EMT-type zeolite nanoparticles (EMT NPs) with particle size of 10–20 nm and external surface area of 200 m2/g have shown high selective affinity toward plasma protein (fibrinogen). Besides, the EMT NPs have demonstrated no adverse effect on blood coagulation hemostasis. Therefore, it was envisioned that the EMT NPs could inhibit possible β-amyloid (Aβ)–fibrinogen interactions that result in the formation of structurally abnormal clots, which are resistant to lysis, in cerebral vessels of patients with Alzheimer disease (AD). To evaluate this hypothesis, the clot formation and degradation of Aβ–fibrinogen in the presence and absence of the EMT zeolite NPs were assessed. The results clearly showed that the delay in clot dissolution was significantly reduced in the presence of zeolite NPs. By formation of protein corona, the EMT NPs showed a negligible reduction in their inhibitory strength. Docking of small molecules (Aβ–fibrinogen) introduced a novel potential inhibitory candidate. The zeolite NPs showed similar inhibitory effects on binding of fibrinogen to both Aβ(25–35) and/or Aβ(1–42). This indicates that the inhibitory strength of these NPs is independent of Aβ sequence, and it is suggested that the zeolite NPs adsorb fibrinogen and specifically obstruct their Aβ binding sites. Therefore, the zeolite NPs can be the safe and effective inhibitors in preventing Aβ–fibrinogen interaction and consequent cognitive damage.Keywords
This publication has 56 references indexed in Scilit:
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?Experimental Gerontology, 2011
- Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerizationProceedings of the National Academy of Sciences, 2010
- Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's DiseaseNeuron, 2010
- Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid β Protein FibrillationACS Chemical Neuroscience, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's diseaseJournal of Experimental Medicine, 2007
- Nucleation of protein fibrillation by nanoparticlesProceedings of the National Academy of Sciences, 2007
- Pathways towards and away from Alzheimer's diseaseNature, 2004